Terlipressin is superior to midodrine/octreotide for hepatorenal syndrome type 1

被引：6
|
作者：
Kalambokis, Georgios N. [1 ]
Baltayiannis, Gerasimos [2 ]
Christodoulou, Dimitrios [2 ]
Christou, Leonidas [1 ]
机构：
[1] Univ Ioannina, Med Sch, Div Internal Med 1, GR-45110 Ioannina, Greece
[2] Univ Ioannina, Med Sch, Dept Gastroenterol, Ioannina, Greece
来源：
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY | 2017年 / 29卷 / 12期
关键词：
MANAGEMENT; CIRRHOSIS; ALBUMIN; ASCITES;
D O I：
10.1097/MEG.0000000000000988
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1428 / 1429
页数：2
相关论文
共 50 条
  • [41] Noradrenaline or terlipressin for hepatorenal syndrome?
    Celis, Pilar
    Rada, Gabriel
    MEDWAVE, 2015, 15 : e6235
  • [42] TERLIPRESSIN AND ALBUMIN VS MIDODRINE PLUS OCTREOTIDE AND ALBUMIN IN THE TREATMENT OF HEPATORENAL SYNDROME IN PATIENTS WITH CIRRHOSIS: RESULTS OF A CONTROLLED CLINICAL TRIAL BY THE ITALIAN ASSOCIATION FOR THE STUDY OF THE LIVER
    Cavallin, Marta
    Merli, Manuela
    Fasolato, Silvano
    Toniutto, Pierluigi
    Salerno, Francesco
    Bernardi, Mauro
    Colletta, Cosimo
    Salinas, Freddy
    Digiacomo, Antonio
    Ridola, Lorenzo
    Fornasiere, Ezio
    Cazzaniga, Massimo
    Caraceni, Paolo
    Gatta, Angelo
    Angeli, Paolo
    HEPATOLOGY, 2011, 54 : 1426A - 1427A
  • [43] Terlipressin and Albumin in Patients with Cirrhosis and Type I Hepatorenal Syndrome
    Sergio Neri
    Davide Pulvirenti
    Mariano Malaguarnera
    Bruno M. Cosimo
    Gaetano Bertino
    Luca Ignaccolo
    Sebasiano Siringo
    Pietro Castellino
    Digestive Diseases and Sciences, 2008, 53 : 830 - 835
  • [44] Low doses of terlipressin and albumin in the type I hepatorenal syndrome
    Pulvirenti, Davide
    Tsami, Aikaterini
    ITALIAN JOURNAL OF MEDICINE, 2008, 2 (03) : 34 - 38
  • [45] Terlipressin and albumin in patients with cirrhosis and type I hepatorenal syndrome
    Neri, Sergio
    Pulvirenti, Davide
    Malaguarnera, Mariano
    Cosimo, Bruno M.
    Bertino, Gaetano
    Ignaccolo, Luca
    Siringo, Sebasiano
    Castellino, Pietro
    DIGESTIVE DISEASES AND SCIENCES, 2008, 53 (03) : 830 - 835
  • [46] MIDODRINE AS A SECONDARY PROPHYLAXIS FOR HEPATORENAL SYNDROME
    Parikh, Pathik
    GUT, 2021, 70 : A68 - A68
  • [47] Board Review Vignette: Lessons Learned in the Management of Hepatorenal Syndrome Type 1 With Terlipressin
    Gonzalez, Stevan A.
    Velez, Juan Carlos Q.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (04): : 520 - 523
  • [48] Terlipressin and albumin for type 1 hepatorenal syndrome: does bacterial infection affect the response?
    Altun, Reskan
    Korkmaz, Murat
    Yildirim, Emre
    Ocal, Serkan
    Akbas, Enver
    Selcuk, Haldun
    SPRINGERPLUS, 2015, 4 : 1 - 6
  • [49] EFFECT OF TERLIPRESSIN VERSUS OCTREOTIDE/ MIDODRINE ON RENAL FUNCTION IN PATIENTS WITH HRS
    Juang, Paul
    Yeary, Julianne
    Owen, Emily
    CRITICAL CARE MEDICINE, 2024, 52
  • [50] Predictors of Response to Therapy with Terlipressin and Albumin in Patients with Cirrhosis and Type 1 Hepatorenal Syndrome
    Nazar, Andre
    Henrique Pereira, Gustavo
    Guevara, Monica
    Martin-Llahi, Marta
    Pepin, Marie-Noelle
    Marinelli, Marcella
    Sola, Elsa
    Eugenia Baccaro, Maria
    Terra, Carlos
    Arroyo, Vicente
    Gines, Pere
    HEPATOLOGY, 2010, 51 (01) : 219 - 226
12345